Filing Details

Accession Number:
0001225208-12-011143
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-05-03 17:18:32
Reporting Period:
2012-05-01
Filing Date:
2012-05-03
Accepted Time:
2012-05-03 17:18:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1099800 Edwards Lifesciences Corp EW Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 364316614
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1308771 B Patrick Verguet One Edwards Way
Irvine CA 92614
Cvp, Europe No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-05-01 6,000 $22.95 54,668 No 4 M Direct
Common Stock Acquisiton 2012-05-01 6,000 $21.96 60,668 No 4 M Direct
Common Stock Disposition 2012-05-01 6,000 $84.95 54,668 No 4 S Direct
Common Stock Disposition 2012-05-01 6,000 $82.25 48,668 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Acquire) Disposition 2012-05-01 6,000 $0.00 6,000 $21.96
Common Stock Employee Stock Option (Right to Acquire) Disposition 2012-05-01 6,000 $0.00 6,000 $22.95
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
80,000 2007-05-11 2013-05-10 No 4 M Direct
0 2006-05-12 2012-05-11 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2011.
  2. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
  3. This transaction was executed in multiple trades at prices ranging from $84.95 to $84.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.